metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P- 30 IMPACT OF SELF-REPORTED ANCESTRY IN HEPATOCELLULAR CARCINOMA IN HISPANIC P...
Journal Information
Vol. 29. Issue S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(February 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(February 2024)
Full text access
P- 30 IMPACT OF SELF-REPORTED ANCESTRY IN HEPATOCELLULAR CARCINOMA IN HISPANIC POPULATIONS
Visits
95
Spencer Goble1, Cindy Narvaez-Barbecho2, Manaswita Tappata2, Jhon Prieto3, Domingo Balderramo4, Enrique Carrera5, Javier Diaz Ferrer6, Marco Arrese7, Andre Boonstra8, Jose Debes2
1 Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Estados Unidos (EEUU)
2 Department of Medicine, University of Minnesota, Minneapolis, Estados Unidos (EEUU)
3 Department of Gastroenterology and Hepatology, Centro de Enfermedades Hepaticas y Digestives, Bogota, Colombia
4 Department of Gastroenterology, Hospital Privado Universitario de Córdoba, Córdoba, Argentina
5 Department of Gastroenterology and Hepatology, Hospital Eugenio Espejo, Quito, Ecuador
6 Department of Gastroenterology, Universidad San Martin de Porres, Lima, Perú
7 Department of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile
8 Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Países Bajos (Holanda)
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 29. Issue S1

Abstracts of the 2023 Annual Meeting of the ALEH

More info
Introduction and Objectives

Hepatocellular carcinoma (HCC) related to non-alcoholic fatty liver disease (NAFLD) is a growing health concern in Latin America. This region has a mixed population with a diverse heritage that is rarely accounted for when looking at epidemiological studies. We aimed to assess the differences in the epidemiology and outcomes of HCC in Latin Americans based on self-reported ancestry.

Materials and Methods

We retrospectively evaluated data from the ESCALON network, which prospectively follows patients in South America. Self- reported ancestry data was categorized as European, Amerindian, African, Asian, Indigenous, or other. For this study we divided ancestry into two categories: European and non-European.

Results

429 individuals with HCC from 6 countries were studied: Argentina (34% n=145), Chile (15% n=66), Ecuador (15% n=63), Peru (15% n=66), Colombia (14% n=60), and Brazil (7% n=29). The median age was 68 years and 65% were male. In those of European ancestry (31% n=131) median age was 66 years and 72% were male. In the non-European ancestry cohort (69% n=298) median age was 67 years and 62% were male. The most common causes of underlying liver disease were hepatitis C virus (38%), followed by alcohol use disorder (25%) in European ancestry and NAFLD (52%) followed by alcohol use disorder in non-European ancestry (23%). Both groups, European and non-European ancestry, had similar proportion of HCC diagnosed under surveillance (40% and 41% respectively) and similar presence of extrahepatic disease (47% and 50% respectively). 26% of those with European ancestry received curative therapy compared to 33% of those with non-European ancestry.

Conclusions

This is the first study addressing ancestry in Latin Americans with HCC. We found that HCC related to NAFLD was more common in patients of non-European descent. Future studies are warranted to better understand the impact of genetics within specific regions of the continent to understand the risk of HCC.

Full text is only aviable in PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos